Savara SVRA
NASDAQ SVRA
$4.81 -0.24 (-4.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Savara (SVRA) Asset Writedowns and Impairment (2012 - 2019)

Updated

Savara (SVRA) recorded Asset Writedowns and Impairment of $19.4 million in Q4 2019.

Analysis

Savara (SVRA) Asset Writedowns and Impairment (2012 - 2019) Analysis & Trends

For FY2019, Savara reported Asset Writedowns and Impairment of $26.85 million, up 23.8% from FY2018.

  • Annual Asset Writedowns and Impairment has a four-year compound annual growth rate of 717.9% (FY2015 to FY2019).
  • Across earlier years, Asset Writedowns and Impairment came in at $21.69 million in FY2018, $6.05 million in FY2016 and $6,000 in FY2015.
  • The Q4 2019 figure is the highest quarterly Asset Writedowns and Impairment since Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Savara 987.97 Mn 987.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 19.40 Mn
Mar 31, 2018 21.69 Mn
Dec 31, 2012 102,625.00
API Access

Savara Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SVRA&period=max&api_key=YOUR_API_KEY